Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Penson

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Urology|June 15, 2007
Pay for performance: rationale and potential implications for urologyChris M Gonzalez, David Penson, Beth Kosiak, et al.
Urology|October 19, 2005
Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?Scott Ramsey, David Veenstra, Lauren Clarke, et al.
Journal of Surgical Oncology|May 10, 2014
The effect of health insurance status on the treatment and outcomes of patients with colorectal cancerAlexander A Parikh, Jamie Robinson, Victor M Zaydfudim, et al.
Urologic Oncology|September 19, 2008
Treatment of a population based sample of men diagnosed with testicular cancer in the United StatesMichael Osswald, Linda C Harlan, David Penson, et al.
Urology Practice|June 20, 2024
Identification of Preference "Phenotypes" in Men With Prostate CancerChristopher Saigal, Brett Hollenbeck, David Penson, et al.
Urology Practice|March 1, 2016
Adoption of Intermittent Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study in American Urology PracticeHuei-Ting Tsai, David Penson, George Luta, et al.
European Urology|April 4, 2017
Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam TherapyFlorian Rudolf Schroeck, Bruce L Jacobs, Sam B Bhayani, et al.
The Journal of Surgical Research|May 17, 2011
Choledocholithiasis management in rural America: health disparity or health opportunity?Benjamin K Poulose, Sharon Phillips, William Nealon, et al.
The Journal of Urology|March 27, 2007
Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes studyJulie N Graff, Motomi Mori, Hong Li, et al.
Medical Care|December 31, 2013
Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer PatientsJoan L Warren, Angela Mariotto, Danielle Melbert, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Urology|June 15, 2007
Pay for performance: rationale and potential implications for urologyChris M Gonzalez, David Penson, Beth Kosiak, et al.
Urology|October 19, 2005
Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?Scott Ramsey, David Veenstra, Lauren Clarke, et al.
Journal of Surgical Oncology|May 10, 2014
The effect of health insurance status on the treatment and outcomes of patients with colorectal cancerAlexander A Parikh, Jamie Robinson, Victor M Zaydfudim, et al.
Urologic Oncology|September 19, 2008
Treatment of a population based sample of men diagnosed with testicular cancer in the United StatesMichael Osswald, Linda C Harlan, David Penson, et al.
Urology Practice|June 20, 2024
Identification of Preference "Phenotypes" in Men With Prostate CancerChristopher Saigal, Brett Hollenbeck, David Penson, et al.
Urology Practice|March 1, 2016
Adoption of Intermittent Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study in American Urology PracticeHuei-Ting Tsai, David Penson, George Luta, et al.
European Urology|April 4, 2017
Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam TherapyFlorian Rudolf Schroeck, Bruce L Jacobs, Sam B Bhayani, et al.
The Journal of Surgical Research|May 17, 2011
Choledocholithiasis management in rural America: health disparity or health opportunity?Benjamin K Poulose, Sharon Phillips, William Nealon, et al.
The Journal of Urology|March 27, 2007
Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes studyJulie N Graff, Motomi Mori, Hong Li, et al.
Medical Care|December 31, 2013
Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer PatientsJoan L Warren, Angela Mariotto, Danielle Melbert, et al.
Pageof 4